Atai Life Sciences (ATAI) News Today $2.18 -0.05 (-2.24%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATAI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to ShareholdersJune 3, 2025 | businesswire.comAtai Life Sciences Stock Rockets On Merger Plans With Beckley Psytech; Retail Traders Eye Every DipJune 3, 2025 | msn.comATAI Life Sciences stock soars on Beckley Psytech merger dealJune 2, 2025 | investing.comATAI Life Sciences Shares Rise on Merger Deal with Beckley PsytechJune 2, 2025 | marketwatch.comATAI Life Sciences Shares Jump Following Merger Announcement with Beckley PsytechJune 2, 2025 | msn.comatai Life Sciences gains maximum exposure to key psychedelic asset with Beckley Psytech mergerJune 2, 2025 | proactiveinvestors.comatai Life Sciences and Beckley Psytech to merge in all-share deal, stock popsJune 2, 2025 | proactiveinvestors.comThiel-Backed Psychedelic Drugmaker Atai to Combine With BeckleyJune 2, 2025 | bloomberg.comatai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health TherapiesJune 2, 2025 | globenewswire.comatai Life Sciences expects key trial data by mid-2025 - ICYMIMay 31, 2025 | proactiveinvestors.comatai Life Sciences to Participate in Upcoming Investor ConferencesMay 29, 2025 | globenewswire.comatai Life Sciences holds annual general meetingMay 23, 2025 | investing.comPhase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says JefferiesMay 21, 2025 | finance.yahoo.comAtai Life Sciences Stock Soars To 3-Month High As Depression Study Yields Promising Results: Retail Bulls CheerMay 21, 2025 | msn.comatai Life Sciences upside highlighted by analysts as more positive data backs Beckley Psytech's depression therapyMay 20, 2025 | proactiveinvestors.comatai Life Sciences reports positive data from mid-stage depression trialMay 20, 2025 | msn.comatai Life Sciences announces positive topline data from Phase 2a treatment-resistant depression studyMay 20, 2025 | proactiveinvestors.comatai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech's Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant DepressionMay 20, 2025 | globenewswire.comatai Life Sciences shares gain momentum ahead of pivotal trial readoutsMay 15, 2025 | proactiveinvestors.comAtai Life Sciences: Progress in Psychedelic Mental Health TreatmentsMay 15, 2025 | tipranks.comatai Life Sciences Initiates Phase 2 Study of EMP-01 for Social Anxiety DisorderMay 14, 2025 | nasdaq.comatai Life Sciences builds clinical momentum in first quarter of 2025May 14, 2025 | proactiveinvestors.comatai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate UpdatesMay 14, 2025 | globenewswire.comatai Life Sciences doses first patient in Phase 2 social anxiety trialMay 13, 2025 | proactiveinvestors.comatai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety DisorderMay 13, 2025 | globenewswire.comAtai Life Sciences: Pipeline And Regulatory Uncertainties Warrant Hold RatingApril 21, 2025 | seekingalpha.comAtai Life Sciences initiated with a Positive at BerenbergApril 5, 2025 | markets.businessinsider.comIs Atai Life Sciences (ATAI) the Best German Stock to Buy According to Hedge Funds?April 2, 2025 | insidermonkey.comatai Life Sciences CEO discusses major data readouts expected through 2025 - ICYMIMarch 29, 2025 | proactiveinvestors.comInsiders Make Huge Purchases of These 4 Biotech StocksMarch 26, 2025 | 247wallst.com Biopharma exec says Bitcoin could help industry through ‘biotech winter’ March 21, 2025 | cointelegraph.comPsychedelic: atai Life Sciences, NRx report quarterly resultsMarch 21, 2025 | markets.businessinsider.com Biopharma exec says Bitcoin could help industry through ‘biotech winter’ March 21, 2025 | cointelegraph.com Biopharma exec says Bitcoin could help industry through ‘biotech winter’ March 21, 2025 | cointelegraph.com Biopharma exec says Bitcoin could help industry through ‘biotech winter’ March 20, 2025 | cointelegraph.comAtai Life Sciences Full Year 2024 Earnings: Misses ExpectationsMarch 20, 2025 | finance.yahoo.comatai Life Sciences entering catalyst-rich period with high-potential data readouts in 2025 and 2026March 18, 2025 | proactiveinvestors.comTD Cowen Keeps Their Buy Rating on ATAI Life Sciences (ATAI)March 17, 2025 | markets.businessinsider.comatai Life Sciences prepares for data readouts from key clinical trials, extends operational runwayMarch 17, 2025 | proactiveinvestors.comAtai Life Sciences reports Q4 EPS (24c), consensus (15c)March 17, 2025 | markets.businessinsider.comatai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate HighlightsMarch 17, 2025 | markets.businessinsider.comAtai Life Sciences announces first patient dosed in Elumina Phase 2 trialMarch 11, 2025 | markets.businessinsider.comatai Life Sciences doses first patient in Phase 2 treatment-resistant depression trialMarch 11, 2025 | proactiveinvestors.comatai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant DepressionMarch 11, 2025 | globenewswire.comAtai Life Sciences completes enrollment of Phase 2b trial of BPL-003March 6, 2025 | markets.businessinsider.comatai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant DepressionMarch 6, 2025 | finance.yahoo.comatai Life Sciences-backed trial in treatment-resistant depression completes patient enrollmentMarch 5, 2025 | proactiveinvestors.comIs Atai Life Sciences N.V. (ATAI) Among Stocks With At Least $20 Million In Insider Spending Recently?March 4, 2025 | insidermonkey.comAtai: Following The Path That Spravato Laid And Moving Beyond ItFebruary 27, 2025 | seekingalpha.comatai Life Sciences to Participate in the TD Cowen 45th Annual Health Care ConferenceFebruary 24, 2025 | globenewswire.com Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address ATAI Media Mentions By Week ATAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATAI News Sentiment▼1.290.87▲Average Medical News Sentiment ATAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATAI Articles This Week▼12▲ATAI Articles Average Week Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IMCR News Today TARS News Today BHC News Today IRON News Today BHVN News Today ARQT News Today DYN News Today EWTX News Today CNTA News Today ADPT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATAI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredAnother market crash is coming - here's whenMagnificent 7 Wipeout: What's Next? The first quarter stock crash and quick recovery has many people confus...Chaikin Analytics | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atai Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.